Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664053 · ClinicalTrials.gov registry record · Phase 4
Effects of DHEA/Exercise on Bone, Muscle and Balance
A Phase 4 study of Osteoporosis and Frailty, sponsored by National Aeronautics and Space Administration (NASA).
- Completed
- Registry status
- Phase 4
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT00664053: Completed Phase 4 study of Osteoporosis and Frailty, sponsored by National Aeronautics and Space Administration (NASA).
NCT00664053 is a Phase 4 study of Osteoporosis and Frailty that has completed, run by National Aeronautics and Space Administration (NASA). The registered enrollment target is 99 participants, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664053, a Phase 4 study of Osteoporosis and Frailty, has completed, sponsored by National Aeronautics and Space Administration (NASA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether muscle strength and balance will improve in women with frailty selected for dehydroepiandrosterone sulfate (DHEAS) levels below 550 ng/dl treated with DHEAS supplementation and Hatha yoga. Investigators believe the effects of both treatments will improve outcomes more than either treatment alone and may be additive; in addition, lean body mass, skeletal muscle mass, markers of bone turnover and physical performance will improve following treatment with DHEA and/or yoga.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- BEHAVIORAL Yoga
- DIETARY_SUPPLEMENT DHEA
- BEHAVIORAL Aerobics
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-10 |
| Phase | Phase 4 |
What the finished NCT00664053 record still lists
NCT00664053 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT00664053 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00664053 about?
NCT00664053 is a clinical study titled "Effects of DHEA/Exercise on Bone, Muscle and Balance". The purpose of this study is to examine whether muscle strength and balance will improve in women with frailty selected for dehydroepiandrosterone sulfate (DHEAS) levels below 550 ng/dl treated with DHEAS supplementation and Hatha yoga. Investigators believe the effects of both treatments will impro...
What is the current status of trial NCT00664053?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 99 participants. The study started on 2004-10. Estimated completion is 2006-10.
What conditions does trial NCT00664053 study?
This clinical trial studies the following conditions: Osteoporosis, Frailty.
What interventions are being tested in trial NCT00664053?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Yoga (BEHAVIORAL), DHEA (DIETARY_SUPPLEMENT), Aerobics (BEHAVIORAL).
Who is sponsoring clinical trial NCT00664053?
This trial is sponsored by National Aeronautics and Space Administration (NASA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00664053 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00664053's enrollment target sits among peer trials
99 39th of 84 higher than 46 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preserving Geriatric Muscle With an Osteoporosis Medication
RECRUITING · Phase 4
-
Combined Anabolic Therapy
RECRUITING · Phase 4
-
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
ACTIVE NOT RECRUITING · Phase 4
-
Denosumab (DMAB) Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis (GIOP): a Pilot Study
ACTIVE NOT RECRUITING · Phase 4
-
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
ACTIVE NOT RECRUITING · Phase 4
-
Trial of Parkinson's And Zoledronic Acid
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia